EichorEICHOR

MedDerm Associates — San Diego, California

Please select the option that best describes you so we can direct you to the right page.

🧭 I'm a patient or caregiverWhat this page is, and how to find trials near you

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near San Diego →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work in clinical researchVerify this profile and open the full entry list

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of MedDerm Associates, compiled from the ClinicalTrials.gov public registry.

28
Registered studies
7
Active
2
Recruiting now
17
Completed
4
Stopped or withdrawn

MedDerm Associates appears in 28 registered studies on ClinicalTrials.gov, spanning 2006–2026, run by 10 different lead sponsors, covering 36 distinct drugs and biologics. The record is weighted toward Phase 3 and Phase 2 (17 and 9 phase tags). 2 studies are recruiting now.

Recruiting now

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
NCT07431177 · Sponsor: Novartis Pharmaceuticals · Started 2026-03
Non-segmental Vitiligo
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis S
NCT05889182 · Sponsor: AbbVie · Started 2023-06
Hidradenitis Suppurativa

Most-studied conditions

Psoriasis · Atopic Dermatitis · Hidradenitis Suppurativa · Cutaneous Lupus Erythematosus

Research activity

Registry entries at this facility span 2006–2026. Phase tags — a study spanning two phases counts under both:

Phase 2
9
Phase 3
17
Phase 4
2

Sponsors running studies here

10 different lead sponsors appear. Most frequent:

AbbVie8 studies
Pfizer6 studies
Janssen Research & Development, LLC3 studies
Novartis Pharmaceuticals3 studies
Amgen2 studies
MedDerm Associates2 studies
ASLAN Pharmaceuticals1 study
Gilead Sciences1 study
Incyte Corporation1 study
Lakefront Biotherapeutics NV1 study

Drugs & biologics studied at this facility

36 distinct investigational and approved compounds appear (dose and formulation variants combined). A ×N marks a compound appearing in more than one entry here.

Placebo ×14Abrocitinib ×6ASLAN004 ×4CP-690,550 ×4Risankizumab ×4secukinumab ×4Brodalumab ×2Dupilumab ×2Guselkumab ×2PF-04965842 ×2Placebo/CP-690,550 ×2Remibrutinib ×2Upadacitinib ×2Ustekinumab ×2Acne Free, ProactivApremilastCC-11050CedirogantDeucravacitinibFilgotinibFilgotinib placeboGIA632Injectable PlaceboJNJ-77242113LanraplenibLanraplenib placeboLutikizumabMatching Placebo to JNJ-77242113Matching Placebo to UstekinumabMOR106PF-06826647PF-06826647 or PlaceboPlacebo ComparatorPlacebo for RisankizumabRuxolitinib CreamVehicle Cream

Recently updated registry entries

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

Compiled from public registry records (ClinicalTrials.gov) as of August 11, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.